Literature DB >> 3763771

Endocrine and behavioural responses to methylphenidate in depression.

P R Joyce, R A Donald, M G Nicholls, J H Livesey, R M Abbott.   

Abstract

Twenty patients with a major depressive disorder and 20 control subjects were subjected to a 1 mg dexamethasone suppression test (DST) and a challenge with intravenous (IV) methylphenidate (MP)(0.3 mg/kg). None of the controls, but 9 depressives, were DST non-suppressors. Among the depressives there were correlations between DST-cortisol and baseline (4 p.m.) levels of cortisol, growth hormone, prolactin and adrenaline. Compared with the controls the depressives had a decreased cortisol response and an enhanced adrenaline response to the MP challenge. The decreased cortisol response was not related to either DST-cortisol or baseline cortisol, but was correlated with the mood response to MP.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763771     DOI: 10.1017/s0033291700010291

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  3 in total

1.  Assessment of methylphenidate-induced changes in binding of continuously infused [(11)C]-raclopride in healthy human subjects: correlation with subjective effects.

Authors:  J I Udo de Haes; R Kortekaas; A Van Waarde; R P Maguire; J Pruim; J A den Boer
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

2.  Methylphenidate-induced activation of the anterior cingulate but not the striatum: a [15O]H2O PET study in healthy volunteers.

Authors:  Joanna I Udo de Haes; R Paul Maguire; Piet L Jager; Anne M J Paans; Johan A den Boer
Journal:  Hum Brain Mapp       Date:  2007-07       Impact factor: 5.038

3.  Mood responses of remitted schizophrenics to methylphenidate infusion.

Authors:  D Robinson; D Mayerhoff; J Alvir; T Cooper; J Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.